Investment Opportunities - Identifying stocks that can rise 1,000% or more is essential for building significant wealth, as these investments can dramatically increase portfolio value [1][2] - Tronox Holdings Plc (TROX), a major producer of titanium dioxide, is highlighted as a potential investment with a projected return to the $20 range, representing a 4X return from current levels [3] - Intellia Therapeutics Inc. (NTLA) has seen its shares drop significantly but shows potential for a 1,000% upside due to promising drug trials and significant backing from Regeneron Pharmaceuticals Inc. [11][12] - WeRide Inc. (WRD), a leading robotaxi firm in China, is positioned for substantial growth with a potential 1,000% upside through 2030 as it expands into international markets [18] Market Trends - The Chinese auto market is evolving rapidly, with local manufacturers producing advanced vehicles that compete with Western models, particularly in the robotaxi sector [13][14] - The number of self-driving taxis in China is expected to grow significantly, with estimates suggesting up to 4 million robotaxis by 2030 [14] Investment Strategies - A quantitative system called Apogee has been developed to identify high-quality stocks that have fallen significantly but show signs of recovery, focusing on the "down a lot, up a little" strategy [3][21] - The system has already identified several companies with potential for substantial gains, emphasizing the importance of recognizing turnaround signals in stock performance [21]

Core Viewpoint - A class action securities lawsuit has been filed against Fiserv, Inc. alleging securities fraud that negatively impacted investors between July 24, 2024, and July 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Fiserv made false statements regarding its Clover platform, which was forced upon Payeezy merchants due to issues with the older platform [2]. - It is alleged that the revenue growth of Clover was artificially inflated by the forced conversions from Payeezy, masking a slowdown in new merchant acquisitions [2]. - Following the conversions, many former Payeezy merchants reportedly switched to competitors due to Clover's high pricing and poor customer service, leading to a significant slowdown in Clover's growth [2]. - The lawsuit asserts that Fiserv's positive statements about Clover's growth strategies and business prospects were materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified period have until September 22, 2025, to request to be appointed as lead plaintiff in the case [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Group 1 - U.S. stock futures showed mixed results, with Dow futures declining approximately 100 points [1] - RH reported second-quarter earnings of $2.93 per share, missing the analyst estimate of $3.20, and quarterly revenue of $899.15 million, which fell short of the Street estimate of $904.64 million [1] - RH shares dropped 11.5% to $201.98 in pre-market trading following the earnings report [2] Group 2 - Rent the Runway, Inc. saw a significant decline of 27.1% to $5.75 in pre-market trading after reporting disappointing second-quarter EPS results [4] - Frequency Electronics Inc experienced an 11% drop to $30.56 in pre-market trading due to downbeat financial results for its first quarter [4] - Zhengye Biotechnology Holding Ltd fell 9.3% to $8.35 in pre-market trading after a previous decline of 11% [4] - Inventiva S.A. dipped 8.5% to $5.28 in pre-market trading after a 4% gain the previous day [4] - Kindly MD, Inc. declined 7.7% to $3.64 in pre-market trading [4] - Tronox Holdings plc fell 5.7% to $4.71 in pre-market trading, with Mizuho analyst John Roberts downgrading the stock from Neutral to Underperform and setting a $4 price target [4] - ABIVAX Société Anonyme decreased by 4.7% to $81.94 in pre-market trading [4] - Certara, Inc. fell 4.3% to $10.45 in pre-market trading [4]

Group 1 - U.S. stock futures showed mixed results, with Dow futures declining approximately 100 points [1] - RH reported second-quarter earnings of $2.93 per share, missing the analyst estimate of $3.20, and quarterly revenue of $899.15 million, which fell short of the expected $904.64 million [1] - RH shares dropped 11.5% to $201.98 in pre-market trading following the earnings report [2] Group 2 - Rent the Runway, Inc. saw a significant decline of 27.1% to $5.75 in pre-market trading after reporting disappointing second-quarter EPS results [4] - Frequency Electronics Inc experienced an 11% drop to $30.56 in pre-market trading due to downbeat financial results for its first quarter [4] - Zhengye Biotechnology Holding Ltd fell 9.3% to $8.35 in pre-market trading after a decline of 11% on the previous day [4] - Inventiva S.A. dipped 8.5% to $5.28 in pre-market trading after a 4% gain on Thursday [4] - Kindly MD, Inc. declined 7.7% to $3.64 in pre-market trading [4] - Tronox Holdings plc fell 5.7% to $4.71 in pre-market trading, with Mizuho analyst John Roberts downgrading the stock from Neutral to Underperform and setting a $4 price target [4] - ABIVAX Société Anonyme decreased by 4.7% to $81.94 in pre-market trading [4] - Certara, Inc. fell 4.3% to $10.45 in pre-market trading [4]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Tronox Holdings plc common stock during the specified Class Period, indicating potential legal issues surrounding the company's financial disclosures and performance [1][5]. Group 1: Lawsuit Details - The class action lawsuit is filed for purchasers of Tronox common stock between February 12, 2025, and July 30, 2025, inclusive [1]. - The lawsuit claims that Tronox provided misleading statements regarding its ability to forecast demand for its products, leading to a decline in sales and increased costs, which ultimately affected revenue projections [5]. Group 2: Investor Information - Investors who purchased Tronox common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Concept - The article discusses investment strategies focusing on identifying companies with strong potential for growth while avoiding those likely to decline, particularly in the context of the basic materials sector and the impact of the AI revolution. Group 1: Investment Strategies - The concept of avoiding poorly rated companies can lead to better investment returns, as evidenced by the performance of S&P 500 companies rated by Moody's in 2020 [3][10]. - Eric Fry's presentation emphasizes the importance of selecting stocks that are expected to rise while avoiding those that are likely to fall, particularly in an era characterized by rapid changes in the market [4][31]. Group 2: Basic Materials Sector Analysis - Tronox Holdings PLC (TROX) is highlighted as a key player in the titanium dioxide market, which is cyclical and dependent on demand from industries like automotive and construction [7][8]. - Despite current low trading prices for Tronox shares, there is optimism for recovery due to ongoing demand for titanium dioxide, supported by recent insider buying [9][12][13]. - The article contrasts Tronox with Alliance Resource Partners LP (ARLP), which is facing challenges due to high extraction costs in the coal industry and declining earnings [22][25][29]. Group 3: Market Trends and Future Outlook - The demand for lithium-ion batteries is expected to rise significantly due to advancements in AI technology and the shift from traditional energy sources [18][21]. - Albemarle Corp. is positioned to benefit from this trend, with a strong balance sheet and low-cost assets, while ARLP is likely to struggle against cheaper competitors and market dynamics [21][30].

Core Viewpoint - The market anticipates Huntsman (HUN) will report a year-over-year decline in earnings due to lower revenues, with a consensus EPS estimate of a loss of $0.15 per share, reflecting a significant decrease of 207.1% compared to the previous year [1][3]. Group 1: Earnings Expectations - Huntsman is expected to report revenues of $1.48 billion, which is a decline of 5.8% from the same quarter last year [3]. - The consensus EPS estimate has been revised down by 35.29% over the last 30 days, indicating a reassessment by analysts [4]. - A positive Earnings ESP of +19.23% suggests that analysts have recently become more optimistic about Huntsman's earnings prospects, despite the stock's Zacks Rank of 5, which complicates predictions of an earnings beat [12]. Group 2: Earnings Surprise History - Huntsman has matched consensus EPS estimates in the past, with no surprise reported in the last quarter where it was expected to post a loss of $0.11 per share and did so [13]. - Over the last four quarters, Huntsman has beaten consensus EPS estimates two times [14]. Group 3: Industry Context - In the Zacks Chemical - Diversified industry, Tronox (TROX) is also expected to report a loss of $0.04 per share, indicating a year-over-year change of -157.1% [18]. - Tronox's revenue is projected to be $777.52 million, down 5.2% from the previous year, with a consensus EPS estimate revised down by 43.1% over the last 30 days [19]. - Tronox has a Zacks Rank of 4 (Sell) and has not beaten consensus EPS estimates in any of the last four quarters, making predictions of an earnings beat difficult [20].

Group 1: Smith & Wesson Brands - Smith & Wesson Brands is currently trading at $8.66, with a 52-week range of $8.38 to $16.85 and a dividend yield of 6.00% [2] - The company faces significant headwinds, including tariffs and revenue deleveraging, which have negatively impacted margins and led to insufficient income to cover the dividend [2][3] - The payout ratio is projected to exceed 150% by the end of fiscal 2025, raising concerns about the sustainability of the dividend [2][3] - Analysts have a consensus rating of Moderate Buy, but sentiment is declining, and the price target is falling, indicating potential further downside risk [4] Group 2: SunCoke Energy - SunCoke Energy is trading at $8.18, with a 52-week range of $7.47 to $12.82 and a dividend yield of 5.86% [6] - The company has headwinds from weaker coal prices; however, its dividend payment is considered safe due to long-term contracts that guarantee cash flow [6][7] - The payout ratio is expected to be around 70% in 2025, which is sustainable for the business [6] - A recent acquisition of Phoenix Global is anticipated to positively impact revenue and profitability, diversifying SunCoke's business [7] - MarketBeat tracks one analyst rating this stock as a Buy, with a price target over 65% above current trading levels, supported by strong institutional ownership [8] Group 3: Tronox Holdings - Tronox Holdings is trading at $5.67, with a 52-week range of $4.35 to $17.45 and a dividend yield of 8.82% [10] - The company reported a net loss for the previous fiscal year, but analysts believe it is at a turning point due to shifts in demand for TiO2 pigments [10][12] - The consensus rating among eight analysts is Moderate Buy, indicating potential for a 50% upside, with recent upgrades from JPMorgan raising the price target to $7 [11] - Tronox's balance sheet is strong enough to sustain the dividend until business conditions improve, with expectations of positive earnings by the end of the fiscal year [12]

Core Insights - Energy Fuels (UUUU) reported a 33.5% decline in revenues in Q1 2025 to $16.9 million due to withholding uranium sales amid falling prices [2][14] - The Heavy Mineral Sands (HMS) segment became the primary revenue contributor, generating $15.5 million from sales of rutile, ilmenite, and zircon [2][14] - The company is cautious about uranium sales in 2025, projecting only 220,000 pounds compared to 450,000 pounds in 2024, as uranium prices have decreased by approximately 12% over the past year [3][4] Revenue and Sales Performance - Q1 2025 revenues dropped to $16.9 million from $25 million in the same quarter last year, primarily due to reduced uranium sales [2][14] - The HMS segment's revenue of $15.5 million came from the sale of 6,836 tons of rutile, 12,852 tons of ilmenite, and 1,429 tons of zircon, mainly from the Kwale Project [2][14] Future Outlook - Energy Fuels does not expect immediate production from the Kwale operation, which is in reclamation, until other projects are operational [4] - The company anticipates continued revenue declines and losses in 2025 due to reduced uranium sales and lower price expectations [4] Strategic Initiatives - The diversification into the HMS sector is seen as beneficial for long-term growth, targeting titanium and zirconium minerals while also producing monazite as a byproduct [5][6] - Energy Fuels acquired Base Resources in 2024, gaining control of the Toliara HMS project in Madagascar, with development expected to resume following the lifting of the project's suspension [7] - The company is also advancing its Bahia HMS project in Brazil and holds an option for up to 49% in the Donald Project in Australia, with a final investment decision expected in late 2025 [8] Industry Comparison - Cameco Corporation (CCJ) reported a 24% increase in Q1 revenues to $789 million, with uranium revenues up 10% to $619 million, indicating a contrasting performance in the uranium sector [11][12] - Energy Fuels shares have increased by 12.5% this year, outperforming the industry's growth of 0.4% [15]

Company Performance - LSB reported a quarterly loss of $0.02 per share, matching the Zacks Consensus Estimate, compared to earnings of $0.12 per share a year ago, representing an earnings surprise of -200% [1] - The company posted revenues of $143.43 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 7.04%, and an increase from year-ago revenues of $138.2 million [2] - Over the last four quarters, LSB has surpassed consensus EPS estimates just once, but has topped consensus revenue estimates three times [2] Stock Performance - LSB shares have declined approximately 22.4% since the beginning of the year, while the S&P 500 has decreased by 6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.23 on $154 million in revenues, and $0.27 on $551.05 million in revenues for the current fiscal year [7] Industry Outlook - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 15% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact LSB's stock performance [5]